Bristol-Myers Squibb, a multinational pharmaceutical company, is committed to its R & D strategy to globalize, while managing costs. It was formed a joint venture with an Indian company that has proven itself, but now faces a strategic decision about how and whether to continue.

Bristol-Myers Squibb, a multinational pharmaceutical company, is committed to its R & D strategy to globalize, while managing costs. It was formed a joint venture with an Indian company that has proven itself, but now faces a strategic decision about how and whether to proceed.
«Hide

from
Vicki L. Sato,
Sen Chai,
Rich Ballenger,
Christine Chi,
Alexander below,
Ross Leimberg
Source: Harvard Business School
18 pages.
Release Date: 4 December 2012. Prod #: 613072-PDF-ENG
BMS-Biocon Research Center: Growing a joint venture in India research HBR case solution